Archives of Dermatological Research

, Volume 308, Issue 8, pp 539–551 | Cite as

Oral lichen planus: a literature review and update

  • Mohammad S. AlrashdanEmail author
  • Nicola Cirillo
  • Michael McCullough


Lichen planus (LP) is a common chronic inflammatory condition that can affect skin and mucous membranes, including the oral mucosa. Because of the anatomic, physiologic and functional peculiarities of the oral cavity, the oral variant of LP (OLP) requires specific evaluations in terms of diagnosis and management. In this comprehensive review, we discuss the current developments in the understanding of the etiopathogenesis, clinical-pathologic presentation, and treatment of OLP, and provide follow-up recommendations informed by recent data on the malignant potential of the disease as well as health economics evaluations.


Oral lichen planus Oral lichenoid reactions Oral lichenoid lesions 


  1. 1.
    Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axell T, Bruce AJ, Carpenter W, Eisenberg E et al (2007) Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(Suppl: S25) e21–12Google Scholar
  2. 2.
    Alrashdan MS, Angel C, Cirillo N, McCullough M (2016) Smoking habits and clinical patterns can alter the inflammatory infiltrate in oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol 121:49–57PubMedCrossRefGoogle Scholar
  3. 3.
    Baccaglini L, Thongprasom K, Carrozzo M, Bigby M (2013) Urban legends series: lichen planus. Oral Dis 19:128–143PubMedCrossRefGoogle Scholar
  4. 4.
    Bagan JV, Ramon C, Gonzalez L, Diago M, Milian MA, Cors R, Lloria E, Cardona F, Jimenez Y (1998) Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:532–536PubMedCrossRefGoogle Scholar
  5. 5.
    Beaird LM, Kahloon N, Franco J, Fairley JA (2001) Incidence of hepatitis C in lichen planus. J Am Acad Dermatol 44:311–312PubMedCrossRefGoogle Scholar
  6. 6.
    Bellman B, Reddy RK, Falanga V (1995) Lichen planus associated with hepatitis C. Lancet 346:1234PubMedCrossRefGoogle Scholar
  7. 7.
    Bermejo-Fenoll A, Lopez-Jornet P (2006) Familial oral lichen planus: presentation of six families. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:e12–e15PubMedCrossRefGoogle Scholar
  8. 8.
    Bolewska J, Reibel J (1989) T lymphocytes, langerhans cells and HLA-DR expression on keratinocytes in oral lesions associated with amalgam restorations. J Oral Pathol Med 18:525–528PubMedCrossRefGoogle Scholar
  9. 9.
    Bornstein MM, Kalas L, Lemp S, Altermatt HJ, Rees TD, Buser D (2006) Oral lichen planus and malignant transformation: a retrospective follow-up study of clinical and histopathologic data. Quintessence Int 37:261–271PubMedGoogle Scholar
  10. 10.
    Brown GR, Lindberg G, Meddings J, Silva M, Beutler B, Thiele D (1999) Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology 116:593–601PubMedCrossRefGoogle Scholar
  11. 11.
    Burkhart NW, Burkes EJ, Burker EJ (1997) Meeting the educational needs of patients with oral lichen planus. Gen Dent 45:126–132 (quiz 143–124) PubMedGoogle Scholar
  12. 12.
    Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C (1999) Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 5:44–49PubMedCrossRefGoogle Scholar
  13. 13.
    Carbone M, Goss E, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, Gandolfo S (2003) Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 32:323–329PubMedCrossRefGoogle Scholar
  14. 14.
    Carrozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME, Roggero S, Rendine S, Ghisetti V (2001) Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 144:803–808PubMedCrossRefGoogle Scholar
  15. 15.
    Carrozzo M, Gandolfo S, Carbone M, Colombatto P, Broccoletti R, Garzino-Demo P, Ghisetti V (1996) Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 25:527–533PubMedCrossRefGoogle Scholar
  16. 16.
    Carrozzo M, Uboldi de Capei M, Dametto E, Fasano ME, Arduino P, Broccoletti R, Vezza D, Rendine S, Curtoni ES, Gandolfo S (2004) Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 122:87–94PubMedCrossRefGoogle Scholar
  17. 17.
    Chamani G, Rad M, Zarei MR, Lotfi S, Sadeghi M, Ahmadi Z (2015) Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. Int J Dermatol 54:996–1004PubMedCrossRefGoogle Scholar
  18. 18.
    Clevers H (2004) At the crossroads of inflammation and cancer. Cell 118:671–674PubMedCrossRefGoogle Scholar
  19. 19.
    Constant SL, Bottomly K (1997) Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 15:297–322PubMedCrossRefGoogle Scholar
  20. 20.
    Cottoni F, Tedde G, Solinas A, Deplano A (1991) Lichen planus associated with anti-liver-kidney microsome-positive chronic active hepatitis and hyperthyroidism. Arch Dermatol 127:1730–1731PubMedCrossRefGoogle Scholar
  21. 21.
    Cribier B, Garnier C, Laustriat D, Heid E (1994) Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 31:1070–1072PubMedCrossRefGoogle Scholar
  22. 22.
    Dalmau J, Puig L, Roe E, Peramiquel L, Campos M, Alomar A (2007) Successful treatment of oral erosive lichen planus with mycophenolate mofetil. J Eur Acad Dermatol Venereol 21:259–260PubMedGoogle Scholar
  23. 23.
    Daramola OO, George AO, Ogunbiyi AO (2002) Hepatitis C virus and lichen planus in Nigerians: any relationship? Int J Dermatol 41:217–219PubMedCrossRefGoogle Scholar
  24. 24.
    Dupin N, Chosidow O, Lunel F, Fretz C, Szpirglas H, Frances C (1997) Oral lichen planus and hepatitis C virus infection: a fortuitous association? Arch Dermatol 133:1052–1053PubMedCrossRefGoogle Scholar
  25. 25.
    Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K (2005) Number V oral lichen planus: clinical features and management. Oral Dis 11:338–349PubMedCrossRefGoogle Scholar
  26. 26.
    Eisenberg E (2000) Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 58:1278–1285PubMedCrossRefGoogle Scholar
  27. 27.
    Epstein JB, Wan LS, Gorsky M, Zhang L (2003) Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:32–37PubMedCrossRefGoogle Scholar
  28. 28.
    Erkek E, Bozdogan O, Olut AI (2001) Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 26:540–544PubMedCrossRefGoogle Scholar
  29. 29.
    Fang KC, Raymond WW, Blount JL, Caughey GH (1997) Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 272:25628–25635PubMedCrossRefGoogle Scholar
  30. 30.
    Farhi D, Dupin N (2010) Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 28:100–108PubMedCrossRefGoogle Scholar
  31. 31.
    Farthing PM, Cruchley AT (1989) Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus. J Oral Pathol Med 18:305–309PubMedCrossRefGoogle Scholar
  32. 32.
    Farthing PM, Matear P, Cruchley AT (1990) The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med 19:81–85PubMedCrossRefGoogle Scholar
  33. 33.
    Gale NPB, D Sidransky, Gale N, Pilch BZ, Sidransky D (2005) Epithelial precursor lesions. In: Evenson JW, Reichart P, Sidransky D (eds) Barnes L. Pathology and genetics. Head and neck tumours. IARC, Lyon, pp 177–181Google Scholar
  34. 34.
    Gonzalez-Moles MA, Scully C, Gil-Montoya JA (2008) Oral lichen planus: controversies surrounding malignant transformation. Oral Dis 14:229–243PubMedCrossRefGoogle Scholar
  35. 35.
    Grinspan D, Diaz J, Villapol LO, Schneiderman J, Berdichesky R, Palese D, Faerman J (1966) Lichen ruber planus of the buccal mucosa. Its association with diabetes. Bull Soc Fr Dermatol Syphiligr 73:898–899PubMedGoogle Scholar
  36. 36.
    Helander SD, Rogers RS 3rd (1994) The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol 30:65–75PubMedCrossRefGoogle Scholar
  37. 37.
    Henriksson E, Mattsson U, Hakansson J (1995) Healing of lichenoid reactions following removal of amalgam. A clinical follow-up. J Clin Periodontol 22:287–294PubMedCrossRefGoogle Scholar
  38. 38.
    Herve P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, Plouvier E, Stephan JL, Bourdeau H, Holler E et al (1992) Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease. Blood 79:3362–3368PubMedGoogle Scholar
  39. 39.
    Ibrahim HA, Baddour MM, Morsi MG, Abdelkader AA (1999) Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis? East Mediterr Health J 5:71–78PubMedGoogle Scholar
  40. 40.
    Ichimura M, Hiratsuka K, Ogura N, Utsunomiya T, Sakamaki H, Kondoh T, Abiko Y, Otake S, Yamamoto M (2006) Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. J Oral Pathol Med 35:167–174PubMedCrossRefGoogle Scholar
  41. 41.
    Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC (2008) Oral graft-versus-host disease. Oral Dis 14:396–412PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Ingafou M, Porter SR, Scully C, Teo CG (1998) No evidence of HCV infection or liver disease in British patients with oral lichen planus. Int J Oral Maxillofac Surg 27:65–66PubMedCrossRefGoogle Scholar
  43. 43.
    Ishii T (1987) Immunohistochemical demonstration of T cell subsets and accessory cells in oral lichen planus. J Oral Pathol 16:356–361PubMedCrossRefGoogle Scholar
  44. 44.
    Ismail SB, Kumar SK, Zain RB (2007) Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 49:89–106PubMedCrossRefGoogle Scholar
  45. 45.
    Issa Y, Brunton PA, Glenny AM, Duxbury AJ (2004) Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:553–565PubMedCrossRefGoogle Scholar
  46. 46.
    Ivanovski K, Nakova M, Warburton G, Pesevska S, Filipovska A, Nares S, Nunn ME, Angelova D, Angelov N (2005) Psychological profile in oral lichen planus. J Clin Periodontol 32:1034–1040PubMedCrossRefGoogle Scholar
  47. 47.
    Jose M, Raghu AR, Rao NN (2001) Evaluation of mast cells in oral lichen planus and oral lichenoid reaction. Indian J Dent Res 12:175–179PubMedGoogle Scholar
  48. 48.
    Juneja M, Mahajan S, Rao NN, George T, Boaz K (2006) Histochemical analysis of pathological alterations in oral lichen planus and oral lichenoid lesions. J Oral Sci 48:185–193PubMedCrossRefGoogle Scholar
  49. 49.
    Kanwar AJ, De D (2010) Lichen planus in childhood: report of 100 cases. Clin Exp Dermatol 35:257–262PubMedCrossRefGoogle Scholar
  50. 50.
    Koray M, Dulger O, Ak G, Horasanli S, Ucok A, Tanyeri H, Badur S (2003) The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis 9:298–301PubMedCrossRefGoogle Scholar
  51. 51.
    Kramer IR, Lucas RB, Pindborg JJ, Sobin LH (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539PubMedCrossRefGoogle Scholar
  52. 52.
    Krutchkoff DJ, Eisenberg E (1985) Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 60:308–315PubMedCrossRefGoogle Scholar
  53. 53.
    Laine J, Kalimo K, Forssell H, Happonen RP (1992) Resolution of oral lichenoid lesions after replacement of amalgam restorations in patients allergic to mercury compounds. Br J Dermatol 126:10–15PubMedCrossRefGoogle Scholar
  54. 54.
    Lajevardi V, Ghodsi SZ, Hallaji Z, Shafiei Z, Aghazadeh N, Akbari Z (2016) Treatment of erosive oral lichen planus with methotrexate. J Dtsch Dermatol Ges 14:286–293PubMedGoogle Scholar
  55. 55.
    Lind PO, Hurlen B, Lyberg T, Aas E (1986) Amalgam-related oral lichenoid reaction. Scand J Dent Res 94:448–451PubMedGoogle Scholar
  56. 56.
    Lo Muzio L, Mignogna MD, Favia G, Procaccini M, Testa NF, Bucci E (1998) The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 34:239–246PubMedCrossRefGoogle Scholar
  57. 57.
    Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F, Carrassi A (2004) Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 151:1172–1181PubMedCrossRefGoogle Scholar
  58. 58.
    Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:40–51PubMedCrossRefGoogle Scholar
  59. 59.
    Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:164–178PubMedCrossRefGoogle Scholar
  60. 60.
    Mergoni G, Ergun S, Vescovi P, Mete O, Tanyeri H, Meleti M (2011) Oral postinflammatory pigmentation: an analysis of 7 cases. Med Oral Patol Oral Cir Bucal 16:e11–e14PubMedCrossRefGoogle Scholar
  61. 61.
    Merry R, Belfield L, McArdle P, McLennan A, Crean S, Foey A (2012) Oral health and pathology: a macrophage account. Br J Oral Maxillofac Surg 50:2–7PubMedCrossRefGoogle Scholar
  62. 62.
    Mignogna MD, Fedele S, Lo Russo L (2006) Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol 42:819–824PubMedCrossRefGoogle Scholar
  63. 63.
    Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E (2004) Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 40:120–130PubMedCrossRefGoogle Scholar
  64. 64.
    Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E (2001) Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Oral Oncol 37:262–267PubMedCrossRefGoogle Scholar
  65. 65.
    Mignogna MD, Lo Russo L, Fedele S (2005) Gingival involvement of oral lichen planus in a series of 700 patients. J Clin Periodontol 32:1029–1033PubMedCrossRefGoogle Scholar
  66. 66.
    Mignogna MD, Lo Russo L, Fedele S, Ruoppo E, Califano L, Lo Muzio L (2002) Clinical behaviour of malignant transforming oral lichen planus. Eur J Surg Oncol 28:838–843PubMedCrossRefGoogle Scholar
  67. 67.
    Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, Morel P (1991) Lichen planus and hepatitis C virus. J Am Acad Dermatol 24:792PubMedCrossRefGoogle Scholar
  68. 68.
    Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T (1995) Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 25:910–914PubMedCrossRefGoogle Scholar
  69. 69.
    O’Neill ID, Scully C (2013) Biologics in oral medicine: ulcerative disorders. Oral Dis 19:37–45PubMedCrossRefGoogle Scholar
  70. 70.
    Parashar P (2011) Oral lichen planus. Otolaryngol Clin North Am 44:89–107 (vi) PubMedCrossRefGoogle Scholar
  71. 71.
    Payeras MR, Cherubini K, Figueiredo MA, Salum FG (2013) Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol 58:1057–1069PubMedCrossRefGoogle Scholar
  72. 72.
    Quispel R, van Boxel OS, Schipper ME, Sigurdsson V, Canninga-van Dijk MR, Kerckhoffs A, Smout AJ, Samsom M, Schwartz MP (2009) High prevalence of esophageal involvement in lichen planus: a study using magnification chromoendoscopy. Endoscopy 41:187–193PubMedCrossRefGoogle Scholar
  73. 73.
    Rojo-Moreno JL, Bagan JV, Rojo-Moreno J, Donat JS, Milian MA, Jimenez Y (1998) Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:687–691PubMedCrossRefGoogle Scholar
  74. 74.
    Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus—a review. J Oral Pathol Med 39:729–734PubMedCrossRefGoogle Scholar
  75. 75.
    Rubaci AH, Kazancioglu HO, Olgac V, Ak G (2012) The roles of matrix metalloproteinases-2, -7, -10 and tissue inhibitor of metalloproteinase-1 in the pathogenesis of oral lichen planus. J Oral Pathol Med 41:689–696PubMedCrossRefGoogle Scholar
  76. 76.
    Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F (2003) NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 201:466–472PubMedCrossRefGoogle Scholar
  77. 77.
    Savage NW, McCullough MJ (2005) Topical corticosteroids in dental practice. Aust Dent J 50:S40–S44PubMedCrossRefGoogle Scholar
  78. 78.
    Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, Holmstrup P, Mutlu S, Porter S, Wray D (1998) Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 9:86–122PubMedCrossRefGoogle Scholar
  79. 79.
    Scully C, Carrozzo M (2008) Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 46:15–21PubMedCrossRefGoogle Scholar
  80. 80.
    Scully C, Diz Dios P (2001) Orofacial effects of antiretroviral therapies. Oral Dis 7:205–210PubMedCrossRefGoogle Scholar
  81. 81.
    Siponen M, Huuskonen L, Laara E, Salo T (2010) Association of oral lichen planus with thyroid disease in a Finnish population: a retrospective case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:319–324PubMedCrossRefGoogle Scholar
  82. 82.
    Skoglund A, Egelrud T (1991) Hypersensitivity reactions to dental materials in patients with lichenoid oral mucosal lesions and in patients with burning mouth syndrome. Scand J Dent Res 99:320–328PubMedGoogle Scholar
  83. 83.
    Soto Araya M, Rojas Alcayaga G, Esguep A (2004) Association between psychological disorders and the presence of Oral lichen planus, Burning mouth syndrome and Recurrent aphthous stomatitis. Med Oral 9:1–7PubMedCrossRefGoogle Scholar
  84. 84.
    Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13:350–365PubMedCrossRefGoogle Scholar
  85. 85.
    Thongprasom K, Dhanuthai K (2008) Steriods in the treatment of lichen planus: a review. J Oral Sci 50:377–385PubMedCrossRefGoogle Scholar
  86. 86.
    Thongprasom K, Luengvisut P, Wongwatanakij A, Boonjatturus C (2003) Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med 32:315–322PubMedCrossRefGoogle Scholar
  87. 87.
    Thongprasom K, Prapinjumrune C, Carrozzo M (2013) Novel therapies for oral lichen planus. J Oral Pathol Med 42:721–727PubMedCrossRefGoogle Scholar
  88. 88.
    Thornhill MH, Pemberton MN, Simmons RK, Theaker ED (2003) Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:291–299PubMedCrossRefGoogle Scholar
  89. 89.
    van der Meij EH, Bezemer PD, van der Waal I (2002) Cost-effectiveness of screening for the possible development of cancer in patients with oral lichen planus. Community Dent Oral Epidemiol 30:342–351PubMedCrossRefGoogle Scholar
  90. 90.
    van der Meij EH, Mast H, van der Waal I (2007) The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective 5-year follow-up study of 192 patients. Oral Oncol 43:742–748PubMedCrossRefGoogle Scholar
  91. 91.
    van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der Waal I (1999) A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:307–310PubMedCrossRefGoogle Scholar
  92. 92.
    van der Meij EH, Schepman KP, van der Waal I (2003) The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:164–171PubMedCrossRefGoogle Scholar
  93. 93.
    van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32:507–512PubMedCrossRefGoogle Scholar
  94. 94.
    Villarroel Dorrego M, Correnti M, Delgado R, Tapia FJ (2002) Oral lichen planus: immunohistology of mucosal lesions. J Oral Pathol Med 31:410–414PubMedCrossRefGoogle Scholar
  95. 95.
    Walton LJ, Macey MG, Thornhill MH, Farthing PM (1998) Intra-epithelial subpopulations of T lymphocytes and Langerhans cells in oral lichen planus. J Oral Pathol Med 27:116–123PubMedCrossRefGoogle Scholar
  96. 96.
    Wee JS, Shirlaw PJ, Challacombe SJ, Setterfield JF (2012) Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients. Br J Dermatol 167:36–43PubMedCrossRefGoogle Scholar
  97. 97.
    Xie S, Ding L, Xiong Z, Zhu S (2012) Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. J Huazhong Univ Sci Technolog Med Sci 32:451–457PubMedCrossRefGoogle Scholar
  98. 98.
    Zhao ZZ, Savage NW, Pujic Z, Walsh LJ (1997) Immunohistochemical localization of mast cells and mast cell-nerve interactions in oral lichen planus. Oral Dis 3:71–76PubMedCrossRefGoogle Scholar
  99. 99.
    Zhou XJ, Sugerman PB, Savage NW, Walsh LJ (2001) Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol 28:72–82PubMedCrossRefGoogle Scholar

Related articles recently published in Archives of Dermatological Research (selected by the journal’s editorial staff)

  1. 100.
    Firth FA, Friedlander LT, Parachuru VP, Kardos TB, Seymour GJ, Rich AM (2015) Regulation of immune cells in oral lichen planus. Arch Dermatol Res 307:333–339PubMedCrossRefGoogle Scholar
  2. 101.
    Nogueira MA, Gavioli CF, Pereira NZ, de Carvalho GC, Domingues R, Aoki V, Sato MN (2015) Human endogenous retrovirus expression is inversely related with the up-regulation of interferon-inducible genes in the skin of patients with lichen planus. Arch Dermatol Res 307:259–264PubMedCrossRefGoogle Scholar
  3. 102.
    Shen Z, Gao X, Ma L, Zhou Z, Shen X, Liu W (2014) Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Arch Dermatol Res 306:441–446PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Mohammad S. Alrashdan
    • 1
    Email author
  • Nicola Cirillo
    • 2
  • Michael McCullough
    • 2
  1. 1.Department of Oral Medicine and Surgery, Faculty of DentistryJordan University of Science and TechnologyIrbidJordan
  2. 2.Melbourne Dental SchoolThe University of MelbourneVictoriaAustralia

Personalised recommendations